IGMS(Delisted)
IGM BiosciencesยทNASDAQ
--
--(--)
IGMS fundamentals
IGM Biosciences (IGMS) released its earnings on Jul 31, 2025: revenue was 143.62M (YoY +11352.95%), beat estimates; EPS was 1.58 (YoY +300.00%), beat estimates.
Revenue / YoY
143.62M
+11352.95%
EPS / YoY
1.58
+300.00%
Report date
Jul 31, 2025
EPS
Revenue
Revenue & Expenses
IGMS has released its 2025 Q2 earnings report, with revenue of 143.62M, reflecting a YoY change of 11353.19%, and net profit of 97.58M, showing a YoY change of 303.72%. The Sankey diagram below clearly presents IGMS's revenue sources and cost distribution.
Key Indicators
IGM Biosciences (IGMS) key financial stats and ratios, covering profitability, financial health, and leverage.
IGM Biosciences (IGMS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
IGM Biosciences (IGMS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
IGM Biosciences (IGMS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does IGM Biosciences (IGMS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track IGM Biosciences (IGMS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
